OOIR: Observatory of International Research

Papers

(The TQCC of Biosocieties is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
Publisher Correction: Citizenship in times of crisis: biosocial state–citizen relations during COVID-19 in Austria	22
Between technology transfer and South–South collaboration: an Indo-Cuban experiment in biopharmaceutical innovation	21
Validating what counts as knowledge: the algorithmic gaze and nested multifocality in the biosciences	21
Horizoning work in a (de-)contaminated village in Fukushima: how are these Japanese urbanites living a normal life there?	19
When sociality fails to produce solidarity: environmental NGOs and the politics of public engagement in contemporary China	10
Making pain social: developing a critical social science of pain	10
Agri-food tech’s building block: narrating protein, agnostic of source, in the face of crisis	6
“Black race”, “Schwarze Hautfarbe”, “Origine africaine”, or “Etnia nera”? The absent presence of race in European pharmaceutical regulation	6
“An entire career in 10 seconds”: on protein chemistry, AI, and the threat of obsolescence	6
Cell freezing and the biology of inexorability: on cryoprotectants and chemical time	6
Hormonal stories: a new materialist exploration of hormonal emplotment in four case studies	6
Conceptualization of genotype–phenotype relationships and the assessment of risk in advertising of direct-to-consumer and preimplantation polygenic tests	6
Choreographies of nearness: self and other in personal cancer immune therapy research	5
Regulating synthetic biology by naturalizing it: the mis-classification of a GE mosquito	5
Making sense of snakebite: the place of biological toxins in social scientific analyses of toxicity	5
Data roles: youth mental health outcome measures and the young people who defy them	4
Post-identifiability in changing sociotechnological genomic data environments	4
Accept no limits: biocontainment and the construction of a safer space for experimentation in xenobiology as a legacy of Asilomar	4
Epistemology of the side effect: anecdote and evidence in the digital age	4
The pharmaceutical commons: conceptual clarifications, a practice example, and a research agenda	4
Challenges in public policy for the implementation of pharmacogenetic tests in Europe	4
What to do with the new molecular publics: the vernacularization of pathogen genomics and the future of infectious disease biosocialities	4
Introduction to the special issue: The Near Human in life science, biomedicine, and care	3
Making death through producing life: Necrovalue and the political economy of death	3
Sanitizing psychedelics: the biopolitics of non-hallucinogenic psychoplastogens	3

Correction: An imagined future community: Taiwan Biobank, Taiwanese genome, and nation-building	3
Turning biodiversity data into evidence: the role of protocols in the epistemology of evidence-based conservation	3
Our thanks to founding editor Professor Nikolas Rose	3
Negotiating the necessity of biomedical animal use through relations with vulnerability	3
Introduction to the special issue: Politics of suspension? Time, space, and control in cryopreservation practices	3
Psychedelic innovations and the crisis of psychopharmacology	3
Processes of encountering: locating urban mental health in the entanglements of weak social relations, material elements and normative orders	3